Trinity Biotech (TRIB) Stock Chart & Stock Price History $1.69 -0.07 (-3.98%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Trinity Biotech Stock Price Performance5 Day Performance-23.18%1 Month Performance+43.22%3 Month Performance-37.87%6 Month Performance+0.60%Year-To-Date Performance-21.21%1 Year Performance-24.55% Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why TRIB Stock Chart for Saturday, November, 2, 2024 TRIB Chart by TradingView Trinity Biotech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$1.76$1.69-3.98%$1.76$1.6765,228 shs$12.88 million10/31/2024$1.87$1.76-5.88%$1.89$1.7256,125 shs$13.42 million10/30/2024$2.02$1.87-7.43%$2.05$1.84119,767 shs$14.25 million10/29/2024$2.20$2.02-8.18%$2.18$1.99177,624 shs$15.39 million10/28/2024$1.93$2.20+13.99%$2.21$1.97363,141 shs$16.76 million10/25/2024$1.83$1.93+5.46%$2.11$1.79854,420 shs$14.71 million Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$1.55$1.83+18.06%$2.05$1.55824,026 shs$13.95 million10/23/2024$1.55$1.55$1.61$1.5263,650 shs$11.81 million10/22/2024$1.63$1.55-4.91%$1.63$1.5295,861 shs$11.81 million10/21/2024$1.71$1.63-4.68%$1.73$1.6181,460 shs$12.42 million10/18/2024$1.76$1.71-2.56%$1.78$1.6757,779 shs$13.03 million10/17/2024$1.78$1.76-1.40%$1.83$1.72158,236 shs$13.37 million10/16/2024$1.68$1.78+5.82%$1.82$1.6583,205 shs$13.57 million10/15/2024$1.72$1.68-2.20%$1.70$1.6185,043 shs$12.82 million10/14/2024$2.00$1.72-14.00%$2.02$1.52310,794 shs$13.11 million10/11/2024$1.81$2.00+10.50%$2.06$1.79453,473 shs$15.24 million10/10/2024$1.73$1.81+4.62%$1.83$1.66218,966 shs$13.79 million10/09/2024$1.56$1.73+11.25%$1.80$1.63382,610 shs$13.18 million10/08/2024$1.36$1.56+14.34%$1.61$1.38335,455 shs$11.85 million10/07/2024$1.20$1.36+13.33%$1.38$1.20160,920 shs$10.36 million10/04/2024$1.16$1.20+3.45%$1.20$1.1225,628 shs$9.15 million10/03/2024$1.18$1.16-1.69%$1.19$1.1551,728 shs$8.84 million10/02/2024$1.17$1.18+0.85%$1.19$1.1082,472 shs$8.99 million10/01/2024$1.10$1.17+6.36%$1.19$1.0993,111 shs$8.92 million09/30/2024$1.09$1.10+0.92%$1.13$1.0574,952 shs$8.38 million09/27/2024$1.15$1.09-5.22%$1.14$1.0987,795 shs$8.31 million09/26/2024$1.19$1.15-3.36%$1.24$1.13209,750 shs$8.77 million09/25/2024$1.25$1.19-4.80%$1.28$1.19144,584 shs$9.07 million09/24/2024$1.25$1.25$1.29$1.2229,898 shs$9.53 million09/23/2024$1.27$1.25-1.57%$1.26$1.15199,913 shs$9.53 million09/20/2024$1.28$1.27-0.78%$1.33$1.22122,517 shs$9.68 million09/19/2024$1.50$1.28-14.67%$1.58$1.221.16 million shs$9.75 million09/18/2024$1.60$1.50-6.25%$1.61$1.491.07 million shs$11.43 million09/17/2024$1.62$1.60-1.23%$1.61$1.56120,100 shs$12.20 million09/16/2024$1.60$1.62+1.25%$1.65$1.5684,684 shs$12.35 million09/13/2024$1.63$1.60-1.84%$1.68$1.58127,813 shs$12.19 million09/12/2024$1.62$1.63+0.62%$1.68$1.59106,946 shs$12.42 million09/11/2024$1.70$1.62-4.71%$1.73$1.61227,387 shs$12.35 million09/10/2024$1.77$1.70-3.95%$1.84$1.65265,273 shs$12.95 million09/09/2024$1.77$1.77$1.79$1.69132,843 shs$13.49 millionCrypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now.09/06/2024$1.76$1.77+0.57%$1.80$1.6863,124 shs$13.49 million09/05/2024$1.74$1.76+1.15%$1.80$1.6595,948 shs$13.41 million09/04/2024$1.80$1.74-3.33%$1.84$1.56179,138 shs$13.26 million09/03/2024$1.99$1.80-9.55%$1.91$1.78264,109 shs$13.72 million09/02/2024$1.99$1.99$2.01$1.88326,900 shs$15.17 million08/30/2024$1.99$1.99$2.01$1.88326,017 shs$15.16 million08/29/2024$2.17$1.99-8.29%$2.18$1.97855,343 shs$15.16 million08/28/2024$2.50$2.17-13.20%$2.40$2.151.78 million shs$16.54 million08/27/2024$2.03$2.50+23.15%$3.39$2.4369.42 million shs$19.05 million08/26/2024$2.00$2.03+1.50%$2.06$1.963.28 million shs$15.47 million08/23/2024$2.23$2.00-10.31%$2.24$1.95276,528 shs$15.24 million08/22/2024$2.23$2.23+0.22%$2.28$2.1112,778 shs$16.99 million08/21/2024$2.35$2.23-5.32%$2.38$2.2231,419 shs$16.95 million08/20/2024$2.41$2.35-2.49%$2.50$2.3237,018 shs$17.91 million08/19/2024$2.42$2.41-0.41%$2.48$2.3136,351 shs$18.37 million08/16/2024$2.30$2.42+5.22%$2.57$2.23307,469 shs$18.45 million08/15/2024$2.63$2.30-12.55%$2.65$2.2961,074 shs$17.53 million08/14/2024$2.46$2.63+6.91%$2.67$2.4727,238 shs$20.04 million08/13/2024$2.42$2.46+1.65%$2.74$2.4110,535 shs$18.75 million08/12/2024$2.59$2.42-6.56%$2.59$2.419,144 shs$18.45 million08/09/2024$2.57$2.59+0.78%$2.60$2.265,091 shs$19.74 million08/08/2024$2.76$2.57-6.88%$2.75$2.5626,885 shs$19.59 million08/07/2024$2.76$2.76$2.99$2.763,834 shs$21.04 million08/06/2024$3.10$2.76-10.97%$3.07$2.7623,777 shs$21.04 million08/05/2024$2.72$3.10+13.97%$3.10$2.0765,226 shs$23.62 million08/02/2024$2.85$2.72-4.56%$2.99$2.6511,495 shs$20.73 million08/01/2024$2.98$2.85-4.36%$3.03$2.6632,080 shs$21.72 million Related Companies Barinthus Biotherapeutics Stock Chart Kronos Bio Stock Chart Precision BioSciences Stock Chart Cidara Therapeutics Stock Chart OS Therapies Stock Chart Kezar Life Sciences Stock Chart Theratechnologies Stock Chart SCYNEXIS Stock Chart Calidi Biotherapeutics Stock Chart Syros Pharmaceuticals Stock Chart Receive TRIB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TRIB) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
